Search

everythinglearnresearchcommunity

for

Search:↓

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Choose deodorants with low allergenic ingredients and follow usage instructions to avoid skin issues.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Certain black hairstyling practices increase the risk of traction alopecia, requiring better management and education.

Skin changes in obesity can indicate metabolic issues but aren't reliable for assessing risk or monitoring treatment.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

The authors maintain there is a significant link between vitamin D deficiency and central centrifugal cicatricial alopecia in Black patients, and call for more research on the topic.

ZDHHC17 methylation may help treat or identify facial skin aging.

Sildenafil may help with some skin conditions and hair growth, but more research is needed.

Anabolic steroid abuse can cause sexual, fertility, and health problems.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Effective PCOS management needs clear roles between primary and specialist care, digital tools, and patient education.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Patients with skin disorders face higher risks of complications in facial cosmetic surgery.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

AGA might indicate higher risk for severe COVID-19.

Substance abuse can cause various skin problems, including marks from injections, sores, premature aging, and increased cancer risk.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Men who go bald before 30 may have a higher risk of heart disease.